Publication | Closed Access

The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: Effect of copolymer 1 on MOG-induced disease

Autoimmune DiseaseNeurological DisorderMedicineCopolymer 1ImmunologyOligodendrocyte GlycoproteinAutoimmunityAutoantibodiesImmunologic DiseaseNeurologyBrain-immune InteractionMultiple SclerosisNeuropathologyNeuroimmunologyNeuroinflammation